U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Resmetirom

Last Revision: April 15, 2024.

Estimated reading time: 1 minute

CASRN: 920509-32-6

image 391555298 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of resmetirom during breastfeeding. Because resmetirom is more than 99% bound to plasma proteins, the amount in milk is likely to be low. If the mother requires resmetirom, it is not a reason to discontinue breastfeeding. Until more data are available, resmetirom should be used with careful infant monitoring during breastfeeding, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Resmetirom

CAS Registry Number

920509-32-6

Drug Class

Breast Feeding

Lactation

Milk, Human

Thyroid Hormone Receptor-Beta Agonists

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK603027PMID: 38652793

Views

Related information

Similar articles in PubMed

  • Review Etrasimod.[Drugs and Lactation Database (...]
    Review Etrasimod.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Zuranolone.[Drugs and Lactation Database (...]
    Review Zuranolone.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Cinacalcet.[Drugs and Lactation Database (...]
    Review Cinacalcet.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Baloxavir.[Drugs and Lactation Database (...]
    Review Baloxavir.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Daridorexant.[Drugs and Lactation Database (...]
    Review Daridorexant.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...